文献速递泌尿系结石泌尿系感染

葡萄糖灌注作为盆腔重建手术中观察输尿管喷尿的替代方法

Dextrose Instillation as an Alternative Agent to Observe Ureteral Efflux During Pelvic Reconstructive Surgery.
PubMed 文献 · Urology · 2018-06-26

本研究回顾性分析了2016年6月至2017年6月期间盆腔重建手术中行膀胱镜检查的63例患者,比较了膀胱内直接灌注50%葡萄糖(D50)与未灌注患者的术后尿路感染率和并发症。结果显示D50组术后尿路感染率为15%(3/20),非D50组为23%(10/43),两组差异无统计学意义(p=0.43),且术后并发症无差异。D50每安瓿成本2.18美元,供应无短缺问题,灌注后可立即观察到输尿管喷尿。

要点

  • 膀胱内灌注50%葡萄糖可即时观察输尿管喷尿,便于术中评估。
  • D50组术后尿路感染率15%,非D50组23%,差异无统计学意义(p=0.43)。
  • D50每安瓿成本2.18美元,供应充足,无短缺问题。

核心结论

  • 葡萄糖是一种安全、经济、易得的试剂,可即时观察输尿管喷尿且不增加术后尿路感染风险。

研究设计与样本

  • 回顾性病历审查,纳入2016年6月至2017年6月期间盆腔重建手术中行膀胱镜检查的患者63例。
  • 患者分为两组:膀胱内直接灌注50%葡萄糖(D50)组20例,未灌注D50组43例。

主要发现

  • D50组术后尿路感染3例(15%),非D50组10例(23%),两组差异无统计学意义(p=0.43)。
  • 两组术后并发症无差异。
  • D50直接灌注膀胱后,术中可立即观察到输尿管喷尿。

关键数值与推荐

  • 每安瓿50%葡萄糖成本2.18美元,供应无短缺问题。
  • D50组术后尿路感染率15%(3/20),非D50组23%(10/43),p=0.43。

临床怎么用

  • 在盆腔重建手术的膀胱镜检查中,可考虑使用50%葡萄糖灌注作为观察输尿管喷尿的替代方法。
  • 该方法成本低、易获得,且不增加术后尿路感染风险。

局限性

  • 回顾性研究,样本量较小(共63例)。
  • 单中心研究,结果需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the use, cost, postoperative urinary tract infection (UTI) rates, and complications of dextrose instillation during cystoscopy. METHODS: The medical records of patients who underwent cystoscopy during pelvic reconstructive surgery between June 2016 and June 2017 were reviewed. Patients were divided into two groups: patients who had one ampule of dextrose 50% (D50) directly instilled and patients who did not have D50 instilled during cystoscopy. Preoperative demographics, UTI rates, and postoperative complications were compared. Pharmaceutical cost and availability were reported by the pharmacy at our institution. RESULTS: Out of 63 patients identified, dextrose instillation was used in 20 patients and no dextrose was used in 43 patients. Each ampule of D50 cost $2.18 and there were no problems with supply shortage. As D50 was directly instilled into the bladder, there was immediate visualization of ureteral efflux at the time of surgery. Three patients (15%) in the dextrose group and 10 patients (23%) in the nondextrose group developed postoperative UTIs. There was no statistically significant difference in postoperative UTI rates between the two groups (p = 0.43) and there were no differences in postoperative complications. CONCLUSION: Dextrose is a safe, cost-effective, readily available agent that provides instantaneous visualization of ureteral efflux without an increased risk of postoperative UTI.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Krishingner GA, Cheng JW, Wagner H, et al. Dextrose Instillation as an Alternative Agent to Observe Ureteral Efflux During Pelvic Reconstructive Surgery. Urology. 2018. PMID: 29958966. doi:10.1016/j.urology.2018.05.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。